ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Premium IconPremium Help Menu
S&P 500
5,560.83
0.58%
Dow Jones
40,527.62
0.75%
US Dollar vs MXN
19.5605
-0.14%
Brent Oil
63.03
-2.39%
Bitcoin
94,931.27
-0.06%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Karyopharm Therapeutics Inc (KPTI)

  7. Karyopharm Therapeutics Inc (KPTI) Noticias

KPTI

Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:KPTI
FechaHoraFuenteTítuloSímboloCompañía
24/04/202515:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KPTIKaryopharm Therapeutics Inc
14/04/202507:24Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:KPTIKaryopharm Therapeutics Inc
14/04/202507:19Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KPTIKaryopharm Therapeutics Inc
14/04/202507:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:KPTIKaryopharm Therapeutics Inc
10/04/202516:23Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KPTIKaryopharm Therapeutics Inc
01/04/202515:05PR Newswire (US)Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KPTIKaryopharm Therapeutics Inc
24/02/202515:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KPTIKaryopharm Therapeutics Inc
24/02/202507:40PR Newswire (US)Karyopharm Announces 1-for-15 Reverse Stock SplitNASDAQ:KPTIKaryopharm Therapeutics Inc
19/02/202506:30PR Newswire (US)Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company ProgressNASDAQ:KPTIKaryopharm Therapeutics Inc
12/02/202506:00PR Newswire (US)Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025NASDAQ:KPTIKaryopharm Therapeutics Inc
13/01/202507:30PR Newswire (US)Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 ObjectivesNASDAQ:KPTIKaryopharm Therapeutics Inc
06/01/202516:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KPTIKaryopharm Therapeutics Inc
02/01/202506:00PR Newswire (US)Karyopharm Announces the Appointment of Lori Macomber as Chief Financial OfficerNASDAQ:KPTIKaryopharm Therapeutics Inc
09/12/202407:00PR Newswire (US)Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate CommunicationsNASDAQ:KPTIKaryopharm Therapeutics Inc
05/12/202415:35Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:KPTIKaryopharm Therapeutics Inc
03/12/202406:00PR Newswire (US)Karyopharm Therapeutics Provides Endometrial Cancer Program UpdateNASDAQ:KPTIKaryopharm Therapeutics Inc
25/11/202406:00PR Newswire (US)Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:KPTIKaryopharm Therapeutics Inc
20/11/202415:05PR Newswire (US)Karyopharm Therapeutics Announces the Appointment of Chief Accounting OfficerNASDAQ:KPTIKaryopharm Therapeutics Inc
14/11/202415:22Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:KPTIKaryopharm Therapeutics Inc
05/11/202407:02Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KPTIKaryopharm Therapeutics Inc
05/11/202406:47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KPTIKaryopharm Therapeutics Inc
05/11/202406:30PR Newswire (US)Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:KPTIKaryopharm Therapeutics Inc
31/10/202407:00PR Newswire (US)Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024NASDAQ:KPTIKaryopharm Therapeutics Inc
31/10/202406:30PR Newswire (US)Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in MyelofibrosisNASDAQ:KPTIKaryopharm Therapeutics Inc
30/10/202415:30PR Newswire (US)Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024NASDAQ:KPTIKaryopharm Therapeutics Inc
03/09/202406:00PR Newswire (US)Karyopharm to Participate at Upcoming Investor ConferencesNASDAQ:KPTIKaryopharm Therapeutics Inc
06/08/202406:30PR Newswire (US)Karyopharm Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:KPTIKaryopharm Therapeutics Inc
31/07/202415:05PR Newswire (US)Karyopharm to Report Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:KPTIKaryopharm Therapeutics Inc
19/07/202415:07Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:KPTIKaryopharm Therapeutics Inc
20/06/202407:01Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:KPTIKaryopharm Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KPTI

Su Consulta Reciente

CCOM
OILBRENT
Brent Oil
COIN
XRPUSD
Ripple
FX
USDMXN
US Dollar vs MXN
NASDAQ
GOOGL
Alphabet
NYSE
MRK
Merck
NYSE
AXP
American Express
CCOM
US30
US 30
FX
EURUSD
Euro vs US Dollar
COIN
AVAXUSD
Avalanche
USOTC
RHHBY
Roche (QX)
PM
XAUUSD
Gold vs US Dollar
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios